1-4 of 4
Zhongpei Huang
Close
Sort by
Journal Articles

Quantification of ADA of Humanized CD19 CAR-T Cell Therapy in R/R LBCL

Zhongpei Huang, Heng Mei, Chenggong Li, Yu Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6870.
https://doi.org/10.1182/blood-2023-188349
Published: 2023
Journal Articles

Multi-Omics Reveal Plasma Molecular Signatures of B-ALL Patients during CAR-T Cell Therapy

Jianghua Wu, Lu Tang, Mengyi Du, Chenggong Li, Haiming Kou, Huiwen Jiang, Wenjing Luo, Yinqiang Zhang, Zhongpei Huang, Danying Liao, Wei Xiong, Heng Mei, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7384–7385.
https://doi.org/10.1182/blood-2022-166674
Published: 2022
Journal Articles

Autophagy Facilitates Cancer-Intrinsic Evasion of CAR T Cell-Mediated Cytotoxicity in B-Cell Malignancies

Heng Mei, Lu Tang, Huan Zhang, Fen Zhou, Mengyi Du, Jianghua Wu, Chenggong Li, Qiuzhe Wei, Wenjing Luo, Yinqiang Zhang, Xindi Wang, ZhaoZhao Chen, Jie Zhou, Zhuolin Wu, Zhongpei Huang, Yuxi Wen, Huiwen Jiang, Danying Liao, Haiming Kou, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 634–635.
https://doi.org/10.1182/blood-2022-168590
Published: 2022
Journal Articles

Bispecific CS1-BCMA CAR-T Cells Are Clinically Active in Relapsed or Refractory Multiple Myeloma: An Updated Clinical Study

Chenggong Li, Xindi Wang, Zhuolin Wu, Wenjing Luo, Yinqiang Zhang, Yun Kang, Jia Xu, Zhongpei Huang, Mengyi Du, Lu Tang, Jianghua Wu, Danying Liao, Haiming Kou, Cong Lu, Huiwen Jiang, Qiuzhe Wei, Sha Ke, Jing'e Zheng, Wei Xiong, Jun Deng, Yu Hu, Heng Mei
Journal: Blood
Blood (2022) 140 (Supplement 1): 4573–4574.
https://doi.org/10.1182/blood-2022-170686
Published: 2022